Clinical Trials Browser

Withdrawn × Leflunomide × Plasma cell × Clear all

NCT03952832 2019-11-14

Leflunomide in Treating Patients With High-Risk Smoldering Multiple Myeloma

Phase 2 Withdrawn

Smoldering Multiple Myeloma